Jana Hof
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Cancer therapeutics and mechanisms
Most-Cited Works
- → Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL(2013)347 cited
- → Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition(2014)253 cited
- → Mutations and Deletions of the TP53 Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic Leukemia(2011)204 cited
- → Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases(2016)143 cited
- → The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse(2014)119 cited
- → Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia(2017)89 cited
- → Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia(2012)87 cited
- → Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation(2015)81 cited
- → High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse(2011)75 cited
- → A Concise, Stereocontrolled Total Synthesis of Rippertenol(2011)46 cited